% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Longarino:177254,
author = {F. Longarino$^*$ and T. Tessonnier and S. Mein$^*$ and S.
B. Harrabi and J. Debus$^*$ and W. Stiller and A. Mairani},
title = {{D}ual-layer spectral {CT} for proton, helium, and carbon
ion beam therapy planning of brain tumors.},
journal = {Journal of applied clinical medical physics},
volume = {23},
number = {1},
issn = {1526-9914},
address = {Reston, Va.},
publisher = {ACMP},
reportid = {DKFZ-2021-02388},
pages = {e13465},
year = {2022},
note = {#EA:E050# / Volume23, Issue1 January 2022 e13465},
abstract = {Pretreatment computed tomography (CT) imaging is an
essential component of the particle therapy treatment
planning chain. Treatment planning and optimization with
charged particles require accurate and precise estimations
of ion beam range in tissues, characterized by the stopping
power ratio (SPR). Reduction of range uncertainties arising
from conventional CT-number-to-SPR conversion based on
single-energy CT (SECT) imaging is of importance for
improving clinical practice. Here, the application of a
novel imaging and computational methodology using dual-layer
spectral CT (DLCT) was performed toward refining
patient-specific SPR estimates. A workflow for DLCT-based
treatment planning was devised to evaluate SPR prediction
for proton, helium, and carbon ion beam therapy planning in
the brain. DLCT- and SECT-based SPR predictions were
compared in homogeneous and heterogeneous anatomical
regions. This study included eight patients scanned for
diagnostic purposes with a DLCT scanner. For each patient,
four different treatment plans were created, simulating
tumors in different parts of the brain. For homogeneous
anatomical regions, mean SPR differences of about $1\%$
between the DLCT- and SECT-based approaches were found. In
plans of heterogeneous anatomies, relative (absolute) proton
range shifts of $0.6\%$ (0.4 mm) in the mean and up to
$4.4\%$ (2.1 mm) at the distal fall-off were observed. In
the investigated cohort, $12\%$ of the evaluated
organs-at-risk (OARs) presented differences in mean or
maximum dose of more than 0.5 Gy (RBE) and up to 6.8 Gy
(RBE) over the entire treatment. Range shifts and dose
differences in OARs between DLCT and SECT in helium and
carbon ion treatment plans were similar to protons. In the
majority of investigated cases (75th percentile), SECT- and
DLCT-based range estimations were within 0.6 mm.
Nonetheless, the magnitude of patient-specific range
deviations between SECT and DLCT was clinically relevant in
heterogeneous anatomical sites, suggesting further study in
larger, more diverse cohorts. Results indicate that patients
with brain tumors may benefit from DLCT-based treatment
planning.},
keywords = {brain tumors (Other) / dual-layer spectral CT (Other) / ion
beam therapy planning (Other) / range uncertainties (Other)
/ stopping power (Other)},
cin = {E050 / E210 / HD01},
ddc = {530},
cid = {I:(DE-He78)E050-20160331 / I:(DE-He78)E210-20160331 /
I:(DE-He78)HD01-20160331},
pnm = {315 - Bildgebung und Radioonkologie (POF4-315)},
pid = {G:(DE-HGF)POF4-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:34724327},
doi = {10.1002/acm2.13465},
url = {https://inrepo02.dkfz.de/record/177254},
}